Activin a directs striatal projection neuron differentiation of human pluripotent stem cells

Abstract

The efficient generation of striatal neurons fromhumanembryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) is fundamental for realising their promise in disease modelling, pharmaceutical drug screening and cell therapy for Huntington’s disease. GABAergic medium-sized spiny neurons (MSNs) are the principal projection neurons of the striatumand specifically degenerate in the early phase ofHuntington’s disease.Herewe report that activin A induces lateral ganglionic eminence (LGE) characteristics in nascent neural progenitors derived from hESCs and hiPSCs in a sonic hedgehog-independent manner. Correct specification of striatal phenotype was further demonstrated by the induction of the striatal transcription factors CTIP2,GSX2 and FOXP2.Crucially, these human LGE progenitors readily differentiate into postmitotic neurons expressing the striatal projection neuron signature marker DARPP32, both in culture and following transplantation in the adult striatumin a rat model of Huntington’s disease. Activin-induced neurons also exhibit appropriate striatal-like electrophysiology in vitro. Together, our findings demonstrate a novel route for efficient differentiation of GABAergic striatal MSNs from human pluripotent stem cells.